Bernard Coulie

CIK 1808895 · President and CEO · last filed 2026-04-17

Bernard Coulie is a President and CEO who has filed 36 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for PLRX, was dated Apr 17, 2026. Across all open-market trades the lifetime net is −$13.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $979.0K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$979.0K

Companies

3

Total Filings

36

Lifetime Open-Market Net

-$13.58M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PLRX President and CEO 914,918 $1.07 $979.0K -$13.58M 32 2026-04-17
SEPN Director $33.97 $0 1 2025-06-20
SQZ Biotechnologies Co (SQZ) Delisted Director $0.43 $0 3 2023-06-15

Recent Filings

36 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-04-17 PLRX Mixed $0 EDGAR
2026-01-26 PLRX Grant (A) $0 EDGAR
2026-01-22 PLRX Sell (S) −89,375 -$114.4K EDGAR
2025-06-20 SEPN Grant (A) $0 EDGAR
2025-01-27 PLRX Grant (A) +162,500 $0 EDGAR
2025-01-22 PLRX Sell (S) −52,419 -$587.2K EDGAR
2024-07-12 PLRX Sell (S) −38,710 -$447.5K EDGAR
2024-07-11 PLRX Grant (A) +75,625 $0 EDGAR
2024-01-24 PLRX Grant (A) +128,150 $0 EDGAR
2024-01-19 PLRX Sell (S) −25,721 -$443.2K EDGAR
Showing 110 of 36
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.